Comparison of Standard of Care or Treatment on Protocol
| Status: | Archived |
|---|---|
| Conditions: | Skin Cancer, Cancer, Gastrointestinal, Urology |
| Therapuetic Areas: | Gastroenterology, Nephrology / Urology, Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | March 2009 |
| End Date: | March 2020 |
Randomized Study of Patients (Patient Choice) Who Are Not Eligible for Variations of Standard of Care Protocols When Treated Either on Best Standard of Care Pathways or Per a Protocol Arm That They Failed to Enroll to
Patient will choose to either receive the standard of care according to National
Comprehensive Cancer Network (NCCN) or approved guidelines for their condition or to be
treated according to one arm of the protocol that they could not be enrolled on. The
selection of the arm will be at physician discretion.
All patients failing to enroll in a specific therapeutic research protocol using FDA
approved drugs or CTMS accepted therapies will be screened for this study. Patients will be
randomized (Patient own choice) to either standard of care described in the NCCN guidelines
and published as peer-reviewed phase II or III studies which show an efficacy or to one of
the arms of the protocol they fail to enroll in, as determined by the treating physician.
We found this trial at
1
site
University of New Mexico Founded in 1889 as New Mexico’s flagship institution, the University of...
Click here to add this to my saved trials
